Coverage of COVID-19

Editor-in-Chief: Bruce J. Melancon, PhD

ASSAY and Drug Development Technologies is proud to highlight this virtual collection dedicated to COVID-19 drug repurposing, drug development, and drug discovery peer-reviewed content. We are honored to present this research free to access through June 30, 2022.

Are you working on drug repurposing, drug development, or drug discovery COVID-19 research? Submit your work today!